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SeizuresAlpha-lipoic acid has some neuroprotective properties, but this action has not been investigated in models of
epilepsy. The aim of the present study was to investigate the protective efﬁcacy of α-lipoic acid (lipoic acid)
against pilocarpine-induced cell death through the caspase-dependent or -independent mitochondrial
apoptotic pathways. Wistar rats were injected intraperitoneally with 0.9% saline (control group), pilocarpine
(400 mg/kg, pilocarpine group) alone, orα-lipoic acid (20 mg/kg) in associationwith pilocarpine (400 mg/kg)
30 min before administration of α-lipoic acid. After the treatments all groups were observed for 24 h. Cell
death was reduced in lipoic acid-treated rats. Cytosolic translocation of cytochrome c and subsequent
activation of caspase-3 were reduced by lipoic acid treatment. AIF nuclear translocation and subsequent large-
scale DNA fragmentation were also decreased in lipoic acid-treated rats. Our study suggests that lipoic acid
inhibits both caspase-dependent and -independent apoptotic pathways and may be neuroprotective against
hippocampal damage during pilocarpine-induced seizures.ro Petrônio Portella, Centro de
armacologia da Universidade
zil. Tel./fax: +55 86 3215.
as).
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Alpha-lipoic acid is a disulphide derivative of octanoic acid and has
been used safely for decades due to the presence of a crucial prosthetic
group of various cellular enzymatic complexes (Packer et al., 1995;
Tardif, 2008). In addition, α-lipoic acid has been characterized as an
efﬁcient antioxidant since it is a potential therapeutic agent in the
treatment or prevention of different pathologies that may be related
to an imbalance of the oxido-reductive cellular status (Han et al.,
1997; Moini et al., 2002).
It has been reported that α-lipoic acid exerts protective effects in
neurodegeneration, ischemia-reperfusion, polyneuropathy, diabetes,
AIDS, seizures and hepatic disorder status (Maczurek et al., 2008;
Packer et al., 1999, 1997). The precise mechanism of neuroprotective
effects of α-lipoic acid remains unclear. It is known that α-lipoic acid
can inhibit microglial activation and caspase-related apoptotic path-
ways (Bustamante et al., 1995). Recently, it was reported that
inhibition of caspase-independent mitochondrial pathways, such as
the nuclear translocation of apoptosis-inducing factor (AIF), is also
involved in protective action of lipoic acid (Selvakumar et al., 2006).Apart from stroke, epilepsy is the most common neurological
disorder with 0.5% of prevalence (Browne and Holmes, 2001). The
pilocarpine treatment in rats is an experimental model largely used to
study the pathophysiology of seizures and status epilepticus (SE)
(Freitas et al., 2003; Treiman, 1990). Although there are some
contradictory reports, a potent neuroprotective effect of α-lipoic
acid has been found in various animal models of neurological diseases
(Ferreira et al., 2009; Holmquist et al., 2007;Militão et al., 2010). Thus,
we investigated whether α-lipoic acid can reduce hippocampal cell
death after pilocarpine injection in rats which has been accepted as a
model of temporal lobe epilepsy (Freitas et al., 2003; Turski et al.,
1983; Xavier et al., 2007). We further investigated whether caspase-
dependent or -independent apoptotic pathway was involved in the
neuroprotective effects of α-lipoic acid.
2. Material and methods
2.1. Animal procedures
Male Wistar rats (250-280 g; 2-month-old) were obtained from
Central Animal House of the Federal University of Piaui, Piaui, Brazil.
They were maintained on a 12:12 h light/dark cycle (lights on 07:00–
19:00 h) in air conditioned constant temperature (22±1 °C) colony
room, with free access to water and 20% (w/w) protein commercial
chow. Animal care followed the ofﬁcial governmental guidelines in
Table 1
Effect of pretreatment with lipoic acid on pilocarpine-induced seizures and lethality in
adult rats.
Groups Latency to ﬁrst
seizures (min)
Percentage
seizures
Percentage
survival
Number of
animals/group
Pilocarpine 35.00±0.70 60 40 24
LA plus pilocarpine 89.00±1.95c 10a 100a 24
LA 00 00a,b 100a 24
Animals were pretreated acutely, intraperitoneally, with lipoic acid and 30 min after
receiving pilocarpine 400 mg/kg, i.p. Results for latency to ﬁrst seizure are expressed as
mean±S.E.M. Result for percentage seizures and percentage survival are expressed as
percentages of the number of animals from each experimental group.
apb0.0001 compared with the pilocarpine group (χ2-test).
bpb0.0001 compared with LA plus pilocarpine group (χ2-test).
cpb0.0001 compared with the pilocarpine group (ANOVA and Student–Newman–Keuls
test).
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Committee of the Federal University of Piauí, Brazil. All chemicals
were obtained from Sigma Chemical Co. (St. Louis, MO, USA). All doses
are expressed in milligrams per kilogram and were administered in a
volume of 10 ml/kg injected intraperitoneally (i.p.).
In a set of experiments, the animalswere divided into four groups and
treated with α-lipoic acid (20 mg/kg, i.p., n=24) or 0.9% saline (i.p.,
n=24) and 30 min later, they received pilocarpine hydrochloride
(400 mg/kg, i.p.). Within this 30-min interval, the rats were observed
for the occurrence of any change in behavior. The treatments previously
described represent the LA plus pilocarpine and pilocarpine groups,
respectively. Other two groups received 0.9% saline (i.p., n=24, control
group) orα-lipoic acid alone (20 mg/kg, i.p., n=24, LA group). After the
treatments, the animals were placed in 30 cm×30 cm chambers to
record: latency to ﬁrst seizure, any one of the behavioral indices typically
observed after pilocarpine administration: wild running, clonus, tonus,
clonic–tonic seizures (Turski et al., 1983), and number of animals that
died during 1 h after pilocarpine administration.
Previous work have shown that the numbers of convulsions and
deaths occurring within 24 h post injection always follow the same
pattern, so we decided to observe the animals for 24 h as pilocarpine-
induced convulsions occur in 30–60 min and deaths within 24 h after
pilocarpine injection. The survivors were killed by decapitation and
their brains were dissected out on ice to remove hippocampus for
caspase-dependent or -independent apoptotic determinations. The
pilocarpine groupwas constituted by those rats that presented seizures.
The drug dosageswere determined fromboth dose–response studies,
including pilocarpine (data not shown), and observations of the doses
currently used in animals studies in the literature (Freitas, 2009; Santos
et al., 2008; Xavier et al., 2007). The doses used are not equivalent to
those used by humans because rats have different metabolic rates.Fig. 1. Reduction of hippocampal cell death by lipoic acid. Comparison of severity of lesion w
100 (total) percentage of hippocampus involvement. Brain damage was considered positive
staining (HE). Pictures (100 ×) shown are from one representative experiment of n=5. Le2.2. Histopathological investigation in hippocampus
All groups were closely observed during 24 h for behavioral
changes and convulsive state. Animals were sacriﬁced by decapitation
24 h after the treatment and brains were dissected out and ﬁxed in
formalin 10%. After an initial coronal section at the level of the optic
nerve, 3–5 μm thick sections were prepared and stained with
hematoxylin and eosin (HE) for light microscopy studies (100 ×).
The degree of hippocampal damage severity was deﬁned by a scale
ranging from 0 (none) to 100 (total) by light microscopy and
previously deﬁned to be reliable for morphological analysis (Paxinos
and Watson, 2007). Brain damage presence was conﬁrmed if
hippocampus showed at least 50% involvement. To detect DNA
fragmentation, terminal deoxynucleotidyl transferase-mediated uri-
dine 5′-triphosphatebiotin nick end-labeling (TUNEL) (Roche Diag-
nostics GmbH, Penzberg, Germany) was performed (Lee et al., 2005b).
Using high-powered magniﬁcation (400×), the total number of cells
and the number of TUNEL-positive cells within a grid were counted.
The ratio of the number of TUNEL-positive neurons in CA1 andCA3was
calculated and expressed as percent of the TUNEL-positive cells in each
group (n=4). After washing, 0.5 g/ml of propidium iodide (PI)
(Sigma, St. Louis, MO, USA) was used for counterstaining. Thereafter,
the sections were observed under LSM 510 confocal laser scanning
microscopy (Carl Zeiss, Thornwood, NY, USA). Immunoﬂuorescent
staining was done as previously described (Lee et al., 2005a). Fixed
sections were reacted to primary antibodies, rabbit anti-cytochrome c
(1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), or goat anti-
AIF (1:100; Santa Cruz Biotechnology). After washing, the sections
were incubated with FITC-conjugated donkey anti-rabbit IgG (Jackson
ImmunoResearch, West Grove, PA, USA) or FITC-conjugated donkey
anti-goat IgG (Jackson ImmunoResearch). After counterstaining
with PI, the slides were observed using a confocal laser scanning
microscope (Carl Zeiss).
2.3. DNA fragmentation in hippocampus
To quantify DNA fragmentation, we used commercially prepared
enzyme immunoassay kit to determine cytoplasmic histone-associated
DNA fragments (Roche Diagnostics). After pilocarpine injection,
hippocampus was quickly dissected and subfractionized in lysis buffer.
A cytosolic volume containing 20 μg of protein was used for the ELISA,
following the manufacturer's protocol (n=5). To quantify the caspase-
3 activity, we used a commercially prepared enzyme immunoassay kit
(Chemicon International, Temecula, CA, USA). The cytosolic samples
were prepared as described for the Western blot method (n=5).
Equal amount of protein (20 μg) was used to determine the cleaved
bioluminescent substrate by active caspase-3 and ELISA.as expressed as a mean±S.E.M. of scores of damage based in a scale from zero (none) to
if there was at least 50% hippocampal involvement showed by hematoxylin and eosin
gends: A: saline group; B: pilocarpine group; and C: lipoic acid plus pilocarpine group;
Fig. 3. Reduction of cytochrome c release and AIF nuclear translocation frommitochondria b
treatment. AIF nuclear translocation after pilocarpine injection in Western blot analysis. C
mitochondrial, cytosolic and nuclear subfractions.
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bp<0.001 as compared to pilocarpine group (t-Student-Neuman-Keuls test).
Fig. 2. Semi-quantitative analysis of TUNEL-positive cells in both CA1 and CA3 and
surviving cells in hematoxylin and eosin (HE) staining in lipoic acid-treated rats after
pilocarpine injection.
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in hippocampus
Hippocampal tissues were collected at 24 h after pilocarpine
injection and subfractionized into the mitochondrial, cytosolic, and
nuclear fractions (n=5) (Lee et al., 2005a). Transblots were
incubated with primary antibodies such as rabbit anti-cytochrome c
(1:200; Santa Cruz Biotechnology), rabbit anti-cleaved caspase-3
(1:1000; Cell Signaling Technologies, Beverly, MA, USA), or goat anti-
AIF (1:200; Santa Cruz Biotechnology), respectively. To reveal large-
scale DNA fragmentation, pulse-ﬁeld gel electrophoresis (PFGE) was
performed as previously described (n=5) (Zhang et al., 2002). Using
a CHEF Mammalian Genomic DNA Plug Kit (Bio-Rad, Hercules, CA,
USA), DNA samples was prepared in agarose plugs.
2.5. Statistical analyses
DNA fragmentation and Western blot analysis were compared
using ANOVA and the Student–Newman–Keuls test as post hoc test,
because these results show a parametric distribution. The histopath-
ological analysis was calculated as percentages, and compared with
the Mann–Whitney test. In all situations statistical signiﬁcance was
reached at p less-than-or-equals, slant 0.05. The statistical analyses
were performed with the software GraphPad Prism, Version 3.00 for
Windows, GraphPad Software (San Diego, CA, USA).
3. Results
Pilocarpine induced the ﬁrst seizure at 35.00±0.70 min. All the
animals studied showed generalized tonic–clonic convulsions with
status epilepticus (SE) and 60% survived the seizures. All animals
pretreated with the lipoic acid selected for this study were observedy lipoic acid. Cytosolic release of cytochrome c in Western blot analysis after pilocarpine
OX, cytochrome oxidase. COX-IV, beta-actin and histone H1; internal controls of each
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in behavior, such as peripheral cholinergic signs (100%), tremors
(50%), staring spells, facial automatisms, wet dog shakes, rearing and
motor seizures (10%), developed progressively within 1–2 h into a
long-lasting SE (10%). Result shows that when administered at the
dose (20 mg/kg) before pilocarpine, lipoic acid reduced by 50% the
percentage of animals that seized, increased (154%) latency to the ﬁrst
seizure (89.00±1.95 min) and increased the survival percentage
(60%) when compared to the pilocarpine-treated group (Table 1).
None of the animals that received injections of isotonic saline
(control) or lipoic acid alone showed seizures or histopathological
changes in hippocampus. However, neuronal loss, gliosis, and typical
vacuolar degeneration are observed in the pilocarpine-treated
hippocampus region. Importantly, no histopathological changes are
observed in lipoic acid-treated after policarpine co- administered
hippocampus (Fig. 1).Fig. 4. Inhibition of caspase-dependent and -independent pathways by lipoic acid after piloca
acid in Western blot analysis. Pulse-ﬁeld gel electrophoresis; large-scale DNA fragmenta
treatment, and it was decreased by lipoic acid at 24 h after pilocarpine treatment. Casp
fragmentation among pilocarpine and lipoic acid-treated rats, using cell death assay.In histopathological analysis, surviving cells in hippocampus were
signiﬁcantly increased in lipoic acid-treated rats at 24 h after seizures
compared to pilocarpine-treated rats (pb0.001) (Fig. 1). TUNEL-
positive cells in both CA1 (pb0.001) and CA3 (pb0.0001) were
signiﬁcantly reduced in lipoic acid-treated rats after seizures com-
pared to the pilocarpine-treated group (Fig. 2). Semi-quantitative
analysis of surviving CA1 (pb0.001) and CA3 (pb0.001) cells in
hematoxylin and eosin (HE) staining was signiﬁcantly increased in
lipoic acid-treated rats after seizures (Fig. 2).
In Western blot analysis, cytochrome c immunoreactivity was
evident in the cytosolic fraction of seized rats after pilocarpine
injection, whereas immunoreactivity of cytochrome c in cytosolic
fraction of normal control was barely detected (Fig. 3). The amount of
cytosolic cytochrome cwas signiﬁcantly reduced in lipoic acid-treated
rats at 1 h and 24 h after seizures compared to the pilocarpine group
(pb0.001) (Fig. 3).rpine treatment in hippocampus. Expression of cleaved caspase-3 was reduced by lipoic
tion (mainly ~50 kbp) was shown as early as 1 h and further 24 h after pilocarpine
ase-3 activity assay after pilocarpine and lipoic acid treatment. Comparison of DNA
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cytochrome c in mitochondria in the control rats (without pilocar-
pine). In contrast, lipoic acid-treated rats showed reduction of
cytochrome c immunoreactivity in cytosol, compared to pilocarpine-
treated rats (Fig. 3).
In Western blot analysis, mitochondrial AIF in pilocarpine-treated
rats increased time-dependently after seizures, whereas nuclear AIF in
lipoic acid-treated rats correspondingly decreased after pilocarpine-
induced seizures (Fig. 3). The amount of nuclear AIF in lipoic acid-
treated rats was signiﬁcantly decreased compared to pilocarpine-
treated rats (pb0.001) (Fig. 3). In Western blot analysis, the
immunoreactivity of cleaved caspase-3, the active form of caspase-3,
was increased in seized rats after pilocarpine injection.
The total amount of cleaved caspase-3 was signiﬁcantly reduced in
lipoic acid-treated rats compared to seized rats (pb0.001) (Fig. 4). In
PFGE, large-scale DNA fragmentation (~50 kbp) was increased at 1 h
and further increased at 24 h after pilocarpine treatment. However,
large-scale DNA fragmentation reduced in lipoic acid-treated rats at
24 h after pilocarpine treatment (Fig. 4). Caspase-3 activity was
signiﬁcantly decreased in lipoic acid-treated rats compared to seized
rats at 24 h after pilocarpine treatment (pb0.001). Nevertheless, there
was no signiﬁcant difference in caspase-3 activity between saline and
lipoic acid treatments (Fig. 4). The amount of DNA fragmentation in
cell death assay was signiﬁcantly decreased by lipoic acid-treatment
compared with pilocarpine-treated rats (pb0.001). In addition, the
apoptotic DNA fragmentation in lipoic acid-treated rats was signiﬁ-
cantly less than that of the pilocarpine-treated rats (pb0.001) (Fig. 4).
4. Discussion
All the animals treated with pilocarpine showed generalized
tonic–clonic convulsions with status epilepticus (SE), and 60%
survived the seizures. All animals pretreated with the lipoic acid
selected for this study were observed for 1 h and 24 h before
pilocarpine injection and its manifested alterations in behavior, such
as peripheral cholinergic signs, tremors, staring spells, facial auto-
matisms, wet dog shakes, rearing and motor seizures, which develop
progressively within 1–2 h into a long-lasting SE. Result shows that
when administered at a dose of 20 mg/kg before pilocarpine, lipoic
acid reduced the percentage of animals that seized, increased latency
to the ﬁrst seizure and increased the survival percentage as compared
with the pilocarpine-treated group. Pretreatment with lipoic acid, had
similar effects in two observation periods. Lipoic acid presents an
anticonvulsant effect, improving some parameters related to pilocar-
pine-induced convulsions.
In this study, we demonstrated the ﬁrst evidence thatα-lipoic acid
may provide a neuroprotective effect against rat hippocampal cell
death after pilocarpine treatment through the inhibition of caspase-
dependent and -independent apoptotic pathways. First, α-lipoic acid
reduced DNA fragmentation after pilocarpine treatment. Second, α-
lipoic acid inhibited both the caspase-dependent (cytochrome c
release and the subsequent cleavage of caspase-) and independent
pathways (nuclear translocation of AIF) after pilocarpine-induced
seizures. Furthermore, caspase-3 activity was similarly inhibited
between pan-caspase inhibitor and lipoic acid-treated rats, but the
amount of apoptosis associated DNA fragmentation in lipoic acid-
treated rats was lower than that of the pan-caspase inhibitor-treated
rats. It suggests that the reduction of apoptosis by α-lipoic acid
treatment is related with additional inhibitory function against the
caspase-independent apoptosis along with blocking caspase-depen-
dent pathways. Although present results show that apoptosis might
be critical in pilocarpine-induced hippocampal damage, other cell
death types such as necrosis need to be evaluated.
The recent reports showed that nuclear translocation of AIF (Cheung
et al., 2005), a caspase-independent pathway, as well as the caspase-
dependent cell death pathway (Henshall et al., 2000), is involved inseizure induced apoptotic cell death, and both caspase-dependent
and -independent pathways are inhibited by lipoic acid treatment
(Lovell et al., 2003; Poon et al., 2005). Thus, these reports support
our speculation that lipoic acid may have a neuroprotective role by
reducing apoptosis in both caspase-dependent and -independent
manner after pilocarpine treatment. However, other mechanisms such
as inﬂammation andmicroglial activation still remain to be evaluated in
this model.
In conclusion, our results suggest that lipoic acid inhibits both
caspase-dependent and -independent apoptotic pathways, and the
inhibition of these pathways may contribute to the hippocampal
damage reduction after pilocarpine treatment.
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